Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Phase Ib trial of pridopidine in patients with schizophrenia.

Trial Profile

Phase Ib trial of pridopidine in patients with schizophrenia.

Not stated
Phase of Trial: Phase I

Latest Information Update: 29 May 2012

At a glance

  • Drugs Pridopidine (Primary)
  • Indications Schizophrenia
  • Focus Adverse reactions
  • Sponsors Astellas Pharma
  • Most Recent Events

    • 12 Apr 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top